EPAM Systems, Inc. (EPAM) provides software product development services worldwide.
The company offers product research, design and prototyping, product development, component design and integration, full lifecycle software testing, product deployment and end-user customization, performance tuning, product support and maintenance, and porting and cross-platform migration. It also provides custom application development services, such as business and technical requirements analysis, solution architecture creation and validation, quality assurance and testing, legacy applications re-engineering/refactoring, and cross-platform migration and documentation.
In addition, the company offers software application testing comprising test automation tools and frameworks; testing for enterprise information technology, such as test management, automation, and functional and non-functional testing, as well as defect management; and consulting services focused on helping clients to enhance their existing software testing and quality assurance practices. Further, it provides enterprise application platform services comprising requirements analysis and platform selection, customization, cross-platform migration, implementation, integration, support, and maintenance.
Additionally, the company offers application maintenance and support services, such as incident management, fault investigation diagnosis, work-around provision, application bug fixes, release management, application enhancements, and third-party maintenance services; and infrastructure management services, including application, database, network, server, storage, and systems operations management, as well as incident notification and resolution. It serves independent software vendors and technology, banking and financial services, business information and media, and travel and consumer industry verticals.
Shares have formed a bullish "flag" and higher share prices are expected for this stock. Please note that the firm reports earnings on November 7.
52-Week Tradig Range: $17.70 - 39.76
Entry Point: $36.65
Stop Loss: $34.82
Target Price: $40.31
EPAM fell below our stop loss.